Safety
Research-reported context. This hub organizes the topic into a starting point, core reading, and deeper reference material so mobile readers and search systems can understand the page pathway quickly.
Get oriented first
Begin with the plain-language framing before reading narrower claims or legal and safety details.
Read the central articles
Use the core set to understand the topic before moving into edge cases and supporting references.
Education, not instruction
This section does not provide medical, dosing, sourcing, purchasing, or legal advice.
A consolidated, education-only view of the cautions research flags around psychedelics — psychiatric history, pregnancy data gaps, cardiac and drug concerns.
The valvular-heart-disease hypothesis from chronic 5-HT2B agonism, and why frequent microdosing makes it worth examining. Plausibility is not demonstrated risk.
Challenging Experiences and HPPD: Reported Phenomena, ExaminedAnxiety, panic, difficult experiences, and HPPD as reported phenomena — and how the sub-perceptual microdosing context changes the risk picture. Education only.
Drug-Interaction Safety: How the Literature Frames the RisksA safety-framed overview of psychedelic drug interactions — serotonergic drugs, serotonin syndrome, lithium seizure reports. Routes to Interactions and a clinician.
Harm reduction as a documented public-health concept, plus when and where to seek professional help. Education and routing only — no method detail.
Microdosing Safety: What the Evidence Can and Cannot Tell YouA research-literacy overview of microdosing safety across three axes — physiological, psychological, and evidence quality. Education, not medical advice.
Psychological Safety and Vulnerability: What the Literature FlagsPsychosis, schizophrenia, and bipolar history as literature-flagged cautions for psychedelics. Education about what research warns — not a screening tool.
The Physiological Safety Profile of Classic PsychedelicsWhat controlled studies and drug-harm rankings report about psychedelic toxicity, overdose, dependence, and tolerance — and why this is full-dose data.
Why 'Safe' Is Not a Finding: The Limits of Microdosing Safety ClaimsThe capstone on microdosing safety: why thin, self-selected, full-dose-derived evidence cannot certify 'safe' or 'unsafe', and what real safety data would require.